BR0107493A - Substâncias para uso no tratamento de psorìase - Google Patents

Substâncias para uso no tratamento de psorìase

Info

Publication number
BR0107493A
BR0107493A BR0107493-8A BR0107493A BR0107493A BR 0107493 A BR0107493 A BR 0107493A BR 0107493 A BR0107493 A BR 0107493A BR 0107493 A BR0107493 A BR 0107493A
Authority
BR
Brazil
Prior art keywords
psoriasis
treatment
substances
diacerein
manufacture
Prior art date
Application number
BR0107493-8A
Other languages
English (en)
Inventor
Guido Di Napoli
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medidom Lab filed Critical Medidom Lab
Publication of BR0107493A publication Critical patent/BR0107493A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"SUBSTâNCIAS PARA USO NO TRATAMENTO DE PSORìASE". é revelado o uso de diacereina ou um derivado farmaceuticamente aceitável da mesma para fabricação de uma composição farmacêutica para o tratamento de psoríase ou doenças associadas à mesma, tais como, artrite psoriática.
BR0107493-8A 2000-01-12 2001-01-08 Substâncias para uso no tratamento de psorìase BR0107493A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH532000 2000-01-12
PCT/IB2001/000005 WO2001051044A2 (en) 2000-01-12 2001-01-08 Substances for use in treating psoriasis

Publications (1)

Publication Number Publication Date
BR0107493A true BR0107493A (pt) 2002-10-08

Family

ID=4291590

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0107493A BRPI0107493B8 (pt) 2000-01-12 2001-01-08 substâncias para uso no tratamento de psoríase
BR0107493-8A BR0107493A (pt) 2000-01-12 2001-01-08 Substâncias para uso no tratamento de psorìase

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0107493A BRPI0107493B8 (pt) 2000-01-12 2001-01-08 substâncias para uso no tratamento de psoríase

Country Status (22)

Country Link
US (2) US6844365B2 (pt)
EP (1) EP1248608B1 (pt)
JP (1) JP4912554B2 (pt)
CN (1) CN1187045C (pt)
AR (1) AR026801A1 (pt)
AT (1) ATE254913T1 (pt)
AU (1) AU776324B2 (pt)
BR (2) BRPI0107493B8 (pt)
CA (1) CA2396111C (pt)
CZ (1) CZ301129B6 (pt)
DE (1) DE60101309T2 (pt)
DK (1) DK1248608T3 (pt)
ES (1) ES2210120T3 (pt)
IL (2) IL150390A0 (pt)
MX (1) MXPA02006610A (pt)
PL (1) PL212010B1 (pt)
PT (1) PT1248608E (pt)
RU (1) RU2266740C2 (pt)
SK (1) SK286589B6 (pt)
TR (1) TR200400228T4 (pt)
WO (1) WO2001051044A2 (pt)
ZA (1) ZA200205148B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level
CN1321636C (zh) * 2002-12-30 2007-06-20 北京大学第一医院 大黄酸在抑制血管生成中的应用
NZ608319A (en) 2005-05-16 2014-08-29 Abbvie Biotechnology Ltd Use of tnf inhibitor for treatment of erosive polyarthritis
EP2007426A4 (en) * 2006-04-10 2010-06-16 Abbott Biotech Ltd COMPOSITIONS FOR THE TREATMENT OF PSORIASTIC POLYARTHRITIS AND THEIR APPLICATIONS
US20080085912A1 (en) * 2006-10-06 2008-04-10 Unitech Pharmaceuticals, Inc. Isoxazole derivatives and methods of treating diseases
EP2060562A1 (en) 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
WO2009133430A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Topical compositions of rhein or diacerein
CN101537002B (zh) * 2009-04-24 2012-02-29 安士制药（中山）有限公司 具有优良溶出性能的双醋瑞因组合物及其制备和用途
PT2555618E (pt) * 2010-04-08 2016-03-08 Twi Biotechnology Inc Métodos de utilização da diacereína como terapia adjuvante para a diabetes
WO2017123672A1 (en) * 2016-01-12 2017-07-20 Lawrence Chan Combination treatment for inflammatory diseases
CN106236729A (zh) * 2016-07-31 2016-12-21 合肥远志医药科技开发有限公司 一种双醋瑞因胶囊制剂及其制备方法
CN106692109A (zh) * 2017-01-02 2017-05-24 佛山市腾瑞医药科技有限公司 一种微孔膜控释包衣双醋瑞因微丸及其制备方法
TWI794200B (zh) * 2017-01-19 2023-03-01 安成生物科技股份有限公司 預防或治療免疫發炎性皮膚疾病的方法及醫藥組合物
CN106619555A (zh) * 2017-02-14 2017-05-10 佛山市腾瑞医药科技有限公司 一种双醋瑞因速释微丸制剂、制备方法
CN106667954A (zh) * 2017-02-14 2017-05-17 佛山市腾瑞医药科技有限公司 一种双醋瑞因软胶囊制剂及其制备工艺
CN106727360A (zh) * 2017-02-16 2017-05-31 佛山市腾瑞医药科技有限公司 一种双醋瑞因固体分散体制剂及其制备方法
AU2019245521A1 (en) * 2018-03-29 2020-11-12 S.I.S Shulov Innovative Science Ltd. Pharmaceutical compositions for inhibiting inflammatory cytokines
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
CN112755013A (zh) * 2021-02-22 2021-05-07 北京市中医研究所 大黄酸作为s100a8的抑制剂在炎症性疾病中的制药应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
IT1264545B1 (it) 1993-07-30 1996-10-02 Medidom Lab Procedimento per la preparazione della diacereina
IT1282381B1 (it) 1996-04-29 1998-03-20 Trans Bussan S A Nuove formulazioni di diacereina, ottenute per inclusione del principio attivo in idrogel polisaccaridi
IT1283771B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di derivati della reina
IT1283772B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di reina e diacereina
JP4049406B2 (ja) * 1996-10-15 2008-02-20 正規 小菅 津液改善剤及びそれを含有する経口投与用組成物
JP4018764B2 (ja) * 1996-10-18 2007-12-05 正規 小菅 津液改善用皮膚外用剤
JPH10129556A (ja) 1996-10-28 1998-05-19 Fumiaki Mori 盗難防止自転車
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
IT1297038B1 (it) 1997-12-30 1999-08-03 Medidom Lab Procedimento per la preparazione di reina e suoi diacilderivati

Also Published As

Publication number Publication date
SK9912002A3 (en) 2003-02-04
WO2001051044A2 (en) 2001-07-19
EP1248608A2 (en) 2002-10-16
WO2001051044A3 (en) 2002-03-28
DK1248608T3 (da) 2004-04-05
DE60101309D1 (de) 2004-01-08
JP2003519653A (ja) 2003-06-24
MXPA02006610A (es) 2004-09-10
ZA200205148B (en) 2003-06-26
RU2266740C2 (ru) 2005-12-27
SK286589B6 (sk) 2009-01-07
PL356784A1 (en) 2004-07-12
ATE254913T1 (de) 2003-12-15
DE60101309T2 (de) 2004-09-16
US20050004045A1 (en) 2005-01-06
AU776324B2 (en) 2004-09-02
CN1187045C (zh) 2005-02-02
PL212010B1 (pl) 2012-07-31
CA2396111C (en) 2008-12-02
US6844365B2 (en) 2005-01-18
IL150390A (en) 2007-07-24
EP1248608B1 (en) 2003-11-26
AU2213201A (en) 2001-07-24
TR200400228T4 (tr) 2004-02-23
JP4912554B2 (ja) 2012-04-11
PT1248608E (pt) 2004-04-30
CZ20022382A3 (cs) 2002-11-13
US20020143057A1 (en) 2002-10-03
IL150390A0 (en) 2002-12-01
CZ301129B6 (cs) 2009-11-11
AR026801A1 (es) 2003-02-26
CA2396111A1 (en) 2001-07-19
BRPI0107493B8 (pt) 2021-05-25
CN1395484A (zh) 2003-02-05
BRPI0107493B1 (pt) 2019-04-16
ES2210120T3 (es) 2004-07-01

Similar Documents

Publication Publication Date Title
BR0107493A (pt) Substâncias para uso no tratamento de psorìase
BR9406979A (pt) Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal
NO20021448D0 (no) Nye tiazolo (4,5-D)-pyrimidinforbindelser
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
SV1999000049A (es) Nuevas dihidropirimidinas 2 heterociclicamente sustituidas ref. lea 32793-sv
PT754176E (pt) Novos carbamatos e ureias como modificadores da resistencia a multiplas drogas
DOP2002000429A (es) Imidazotriazinas
SV1999000048A (es) Uso de dihidropiriminas como medicamento y nuevas sustancias ref. lea 32 791-sv
AR029175A1 (es) Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento
DK1104758T3 (da) Acetylenderivativer som anti-inflammatoriske/analgesiske lægemidler
SV1995000042A (es) Heteroaril-oxazolidinonas de 5 eslabones ref. le a 30523-sv
TR200302214T4 (tr) Psoriasis tedavisi için kullanilan pteridine bileşkenleri
ES2194468T3 (es) Uso de derivados del bisindol indigoide para la fabricacion de un medicamento para inhibir quinasas dependientes de ciclinas.
PA8508201A1 (es) Derivados de heterociclo-alquilsulfonil pirazolo como agentes anti-inflamatorios/analgesicos
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
BRPI0410049A (pt) composto ou um sal ou estereoisÈmero farmaceuticamente aceitável do mesmo, uso de um composto, composição farmacêutica, e, kit farmacêutico
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
DE69207301D1 (de) Substituierte 3-Piperazinylalkyl 2,3-Dihydro-4H-1,3-Benzoxazin-4-One, deren Herstellung und Verwendung in Heilkunde
PT1150704E (pt) Melagatran para o tratamento da inflamacao
AR005102A1 (es) Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento.
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
AR035006A1 (es) Derivado de naftiridin-dibenzo[a,d]ciclohepteno-10-acetico, composicion farmaceutica, y el uso de dicho derivado para la fabricacion de un medicamento.
MX9301935A (es) Compuestos para el tratamiento de alteraciones neurodegenerativas.
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM ART. 34 " II " DA LPI ( LEI 9279, DE 14/05/96 ) , O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/04/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/04/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/01/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 08/01/2021